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ABSTRACT
CRISPR-Cas (clustered regularly interspaced short
palindromic repeats-CRISPR-associated) systems
are widespread in archaea and bacteria, and research
on their molecular mechanisms has led to the de-
velopment of genome-editing techniques based on
a few Type II systems. However, there has not been
any report on harnessing a Type I or Type III sys-
tem for genome editing. Here, a method was devel-
oped to repurpose both CRISPR-Cas systems for ge-
netic manipulation in Sulfolobus islandicus, a ther-
mophilic archaeon. A novel type of genome-editing
plasmid (pGE) was constructed, carrying an artificial
mini-CRISPR array and a donor DNA containing a
non-target sequence. Transformation of a pGE plas-
mid would yield two alternative fates to transformed
cells: wild-type cells are to be targeted for chromoso-
mal DNA degradation, leading to cell death, whereas
those carrying the mutant gene would survive the
cell killing and selectively retained as transformants.
Using this strategy, different types of mutation were
generated, including deletion, insertion and point
mutations. We envision this method is readily appli-
cable to different bacteria and archaea that carry an
active CRISPR-Cas system of DNA interference pro-
vided the protospacer adjacent motif (PAM) of an un-
characterized PAM-dependent CRISPR-Cas system
can be predicted by bioinformatic analysis.
INTRODUCTION
Clustered regularly interspaced short palindromic repeats-
CRISPR-associated (CRISPR-Cas) systems function in an-
tiviral defense in prokaryotes and are present in about 90%
of archaeal and 40% of bacterial genomes (1,2). In the cur-
rent classification, most known CRISPR-Cas systems are
classified into three main groups, i.e. Type I, II and III,
each of which is characterized by a signature protein (Cas3,
Cas9 or Cas10) (3). The system is adaptive and functions
in three functional stages (1,2,4–7). First, a DNA segment
(protospacer) is recognized from an invading genetic ele-
ment and inserted into a CRISPR locus immediately after
the leader, becoming the new first spacer of the CRISPR
array. Second, the CRISPR array is transcribed from the
leader region, forming a long precursor transcript that is
processed into mature crRNAs. Finally, crRNAs and Cas
proteins form a ribonucleoprotein complex (crRNP) that
recognizes invading genetic elements by sequence comple-
mentarity between the crRNA and the protospacer and tar-
gets their nucleic acids for destruction via DNA or RNA
interference. DNA targeting in Type I and Type II systems
relies on short conserved sequences defined as protospacer-
adjacent motifs (PAMs), which were first identified from
bioinformatic analyses (8) and functionally demonstrated in
different Type I and Type II CRISPR-Cas systems, and fur-
thermore, DNA interference by all three types of CRISPR-
Cas systems requires a seed sequence (1,2,4–7).
Among the three main classes of CRISPR-Cas systems,
DNA interference by Type II systems only requires a sin-
gle Cas protein, namely Cas9. This protein possesses multi-
ple domains and functions together with two small RNAs,
a mature crRNA and a trans-acting RNA (tracrRNA) in
DNA interference (9–11). Immediately after the discov-
ery, this simplicity has been explored for genome editing
in higher eukaryotes at cellular (10) and organismal lev-
els (12), and the past few years have witnessed an explo-
sion of application of this technology in the globe such that
CRISPR-Cas9 technology has currently been applied in
many different eukaryotes (13–17). Furthermore, CRISPR-
Cas-mediated cell killing has been documented for differ-
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ent bacteria (18–21), and explored for selectively eliminat-
ing specific bacterial species either by using a genetically en-
gineered Type I or Type II CRISPR-Cas system or by repur-
posing their endogenous immune systems of bacterial hosts
(20,22,23). The immune system is also useful in facilitat-
ing generation of genomic island deletion mutants (19,24).
However, method has not been reported for repurposing
any Type I or Type III CRISPR-Cas system for genome
editing.
Wewere interested in developing CRISPR-based genome
editing tools for Sulfolobus islandicus to replace the routine
genetic manipulation tools recently developed for diverse
Sulfolobus species, including S. islandicus, S. acidocaldarius
and S. solfataricus (25–29). Studies on multiple CRISPR-
Cas systems present in S. solfataricus P2 and S. islandicus
REY15A (30,31) have revealed DNA and RNA targeting
activities for S. solfataricus (32–35) and for S. islandicus
(32,36–38). More detailed characterizations of CRISPR-
Cas systems in S. islandicus REY15A, a genetic model of
archaeal research, show that the Type I-A CRISPR-Cas
system mediated DNA interference to invading genetic ele-
ments by specifically recognizing a PAM located at the 5′-
flanking position of the protospacer (32,37). Two PAM se-
quences, i.e. CCN and TCN, were previously identified by
bioinformatic analysis of genomes of Sulfolobus hosts and
their genetic elements (39), and they were found to function
equally well in mediating DNA interference by the Type I-
A system (32,40). Furthermore, genetic analysis of Type I-A
cas genes indicated that depletion of cas6, cas5, cas7, cas3
or casHD by gene deletion inactivated the DNA interfer-
ence by the I-A system, but deleting csa5 did not show any
influence, indicating only csa5 is not essential for the im-
mune system (37). This archaeon also encodes two Type III-
B CRISPR-Cas systems, also named as Cas RAMP mod-
ules (or Cmr systems), one of which is designated as Cmr-
, containing six different Cmr proteins (Cmr-1 through
-6), while the other (Cmr-) possessing seventh different
subunits (41). Six of the seven Cmr- subunits are homolo-
gous to those present in Cmr- while the seventh is unique.
It has been shown that a homologous Cmr- system in
S. solfataricus mediates RNA targeting in vitro and in vivo
(35,42), and we show that the Cmr- system also confers
RNA interference in S. islandicus (38). Furthermore, Cmr-
 is capable of conferring transcription-dependent DNA
targeting (36,38). Therefore, both Type I-A and Type III-
B Cmr- show the potential to be employed for testing
CRISPR-based genome editing in S. islandicus by enabling
self-targeting. Here, we tested Type I-A and III-B CRISPR-
Cas systems for mediating genome editing and found that
both systems greatly facilitate genetic manipulation in this
archaeon.
MATERIALS AND METHODS
Strains, growth conditions and transformation of Sulfolobus
Genetic hosts and mutants constructed in this work are
listed in Table 1. Sulfolobus strains were grown at 78◦C in
a Sucrose-Casamino acids-Vitamin (SCV) medium (0.2%
sucrose, 0.2% casamino acids plus 1% vitamin solution) or
SCVy (SCV + yeast extract (0.0025%)) (43) and uracil was
supplemented to 20 g/ml if required. Sulfolobus compe-
tent cells were prepared as previously described (43) and
transformed by electroporation. All oligonucleotides (Ta-
ble 2) were synthesized in Tsingke, Wuhan, China, and re-
striction enzymes were purchased from ThermoFischer Sci-
entific, Waltham, MA, USA.
Construction of genome-editing plasmids (pGE)
Genome-editing plasmids (pGE) (Table 1) were constructed
individually by cloning a single spacer and amutant allele of
the target gene into pSe-Rp, a Sulfolobus CRISPR-cloning
vector (38). Spacer fragments were generated by annealing
of the corresponding complementary oligonucleotides (Ta-
ble 2) and inserted into pSe-Rp at the BspMI sites, yielding
plasmids carrying an artificial mini-CRISPR array. Then,
donor DNA fragments containing a mutant allele of each
target gene were obtained by splicing and overlap extension
PCR (44) using primers listed in Table 2. The PCR prod-
ucts were digested with Sal I and Not I, and purified again.
The resulting restriction DNA fragments were inserted into
their cognate pAC plasmids at the same sites, giving pGE
plasmids listed in Table 1.
Mutant construction and screening of mutated gene alleles by
PCR
Each pGE plasmid was introduced into a S. islandicus
host indicated in each experiment by electroporation. Af-
ter transformation, pGE plasmids mediated self targeting
to the chromosome of wild-type cells and kill them. Only
mutants can survive the transformation and form colonies
on SCV plates since their chromosomes are devoid of the
target sequence. Transformants were screened by PCR am-
plification of the wild-type target gene and its mutated allele
using primers listed in Table 2. The resulting PCR products
were analyzed by agarose gel electrophoresis and by DNA
sequencing (Tsingke, Wuhan, China).
X-gal assay
-Glycosidase activity encoded by lacS gene was detected
in colonies of Sulfolobus strains by spraying an X-gal
(5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside) solu-
tion of 2 mg/ml onto the colonies on plates and incubating
for a few hours at 78◦C. To detect the enzyme activity in
liquid cultures, X-gal was added to 2 mg/ml (final concen-
tration) and incubated in a 78◦C incubator for 1 h before
observation. Colonies or cultures exhibiting the enzymatic
activity show a deep blue color while those that remain col-
orless are lacS mutants.
Western blotting
S. islandicus Cmr-2-His strain was cultured in SCVy
medium. When the absorbance at 600 nm of the culture
reached 0.4, cell mass was collected by centrifugation, re-
suspended in 50mMphosphate buffer and sonicated. Then,
crude protein samples were loaded on 12% SDS-PAGE and
fractionated according to their sizes. Fractionated proteins
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Table 1. Strains and plasmids used in this work
Strains Genotype and features Reference
S. islandicus E233 pyrEF Deng et al. (27)
S. islandicus cas3 Derived from S. islandicus E233S1, carrying deletion of the entire
gene of cas3
Peng et al. (37)
S. islandicus cmr- Derived from S. islandicus E233, carrying deletion of IIIB Cmr-
locus including 7 cmr- genes
This work
S. islandicus lacS Derived from S. islandicus E233, carrying 43 bp deletion in the lacS
gene
This work
S. islandicus Cmr-2-His Derived from S. islandicus E233, carrying the cmr-2-His gene This work
S. islandicus Cmr-2-HDmut1, 2, 3 Derived from S. islandicus cmr-, carrying one or more mutations
in the HD domain of cmr-2
This work
pSe-Rp Contained a DNA fragment of two tandem copies of CRISPR repeat
used for construct an artificial mini-CRISPR loci
Peng et al. (38)
pAC-lacS1 pSe-Rp carried a CRISPR locus with a spacer matching a
protospacer in the lacS gene of S. islandicus
This work
pGE-lacS1 A genome-editing plasmid derived from pAC-lacS, carrying donor
DNA lacking the target site of the plasmid-born CRISPR
This work
pGE-2-His A genome editing plasmid, carrying an artificial mini-CRISPR locus
with a spacer derived from the stop codon region of cmr-2 and a
donor DNA containing the coding sequence of the tandem 6
Hisditine residues before the stop codon of the target gene
This work
pGE-2HD A genome editing plasmid, carrying an artificial mini-CRISPR with a
spacer derived from the coding sequence of the HD domain and a
donor DNA for HD domain harboring multiple mutations in the HD
domain of the cmr-2 gene
This work
Table 2. Oligonucleotides used in this work
Oligonucleotide Sequence (5′–3′)
LacS-E-SpF AAAGAGTGTAGTAATTAACACCAATCCAGTCTAACCTACCCCTT
LacS-E-SpR TAGCAAGGGGTAGGTTAGACTGGATTGGTGTTAATTACTACACT
LacS-E-SOEF GGGAGGGAGAAGGTTGTGAGAGATGATTTACTGTAGTTAAGAAGACCGAAAAGGGATA
LacS-E-SOER TATCCCTTTTCGGTCTTCTTAACTACAGTAAATCATCTCTCACAACCTTCTCCCTCCC
LacS-E-SalIF ACGCGTCGACTAAACATGTACCATTGGCCC
LacS-E-NotIR ATAAGAATGCGGCCGCCCTTAATGGTCTTATAGGTG
F1 AACTGGCGGTACATAGTGGTA
R1 GGGTAGAAGTGTGTATGAG
F2 GTACAACATTATTCAAGCTC
R2 TTTGATAATCTGCATCATCC
LacS-Seq-F GTGGCTAAATTAACCGATAC
LacS-Seq-R GGCATACTATAAGAGGCAAGG
2-His-SpF AAAGAATACATGTTTGCTCACCTTAAGTAAGATACT
2-His-SpR TAGCAGTATCTTACTTAAGGTGAGCAAACATGTATT
2-His-SOEF ATCTTACTTAAGGCATCATCACCATCACCATTGAGCAAACATGTATTTGCTAATAA
2-His-SOER ATGGTGATGATGCCTTAAGTAAGATACTGCGTAAATTATACTAAGGAACGTTTCTT
2-His-SalIF ACGCGTCGACGGATTTAAGTCATATGCAG
2-His-NotIR ATAAGAATGCGGCCGCCTTTTTGGTTTCCCCATTCTAC
F3 GTAAAGTGTAAAGAAGGAAC
R3 ATGGTGATGGTGATGATG
2-HDmut-SpF AAAGCGACCCTCCTTGGAAGGCATGGGTAATTACAAGGAATATT
2-HDmut-SpR TAGCAATATTCCTTGTAATTACCCATGCCTTCCAAGGAGGGTCG
2-HDmut-SOEF CAACCCTCCTTGGGCCGCATGGGTAGCAACAAGGAATATTAGGGAAGGTCAC
2-HDmut-SOER CCCATGCGGCCCAAGGAGGGTTGTTAAAATAGGCTATTATTTTCTTATTTAAG
2-HDmut-SalIF ACGCGTCGACTAAGGAAAAAGCGATGAGAC
2-HDmut-NotIR ATAAGAATGCGGCCGCGTTCCTTCTTTACACTTTAC
2-Seq-F CCCAATTATTACAATCCTTC
2-Seq-R CACTTGAATACTACCGAACC
1. Restriction sites are underlined whereas 4 nt protruding ends of spacer fragments after primer annealing are shown in bold face.
2. Point mutations in HD domain sequence of cmr-2 are highlighted in red.
were transferred onto a nylon membrane using the Semi-
Dry Electrophoretic Transfer Cell system (Bio-Rad; Her-
cules, CA, USA). The membrane was incubated with a hy-
bridization buffer containing an antiserum against His-tag
peptide (GenScript, Piscataway, NJ, USA) during which the
antiserum bound to His-tagged Cmr-2 protein. The His-
tag antiserum was then recognized by a secondary anti-
body (Goat Anti-Mouse IgG, GenScript) and the protein
bands were visualized by chemiluminescent detection using
the clarity Western ECL substrate (Bio-Rad; Hercules, CA,
USA) and recorded using the MFChemibis 3.2 imaging de-
vice (DNR; Jerusalem, Israel).
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Co-purification
Cell lysate was prepared from a large culture of S. islandi-
cus Cmr-2-His strain and centrifuged for 30 min at 12 000
rpm. The recombinant protein in the supernatant was puri-
fied by Nickel-chelate affinity chromatography (45). Briefly,
500 l Ni-NTA-agarose (Qiagen, Hilden, Germany) was
added to the supernatant and incubated at 4◦C by rotating
end-over-end for 30 min. Agarose beads were then washed
with 10 mlWash Buffer 1 (50 mM phosphate buffer, pH7.4,
500 mM NaCl, 20 mM Imidizole) and 10 ml Wash Buffer
2 (50 mM phosphate buffer, pH 7.4, 500 mM NaCl, 60
mM Imidizole). Recombinant protein was eluted using the
Elution Buffer (50 mM phosphate buffer, pH 7.4, 500 mM
NaCl, 200 mM Imidizole).
RESULTS AND DISCUSSION
Strategy for CRISPR-based genome editing in S. islandicus
The rationale for repurposing Type I-A and III-B CRISPR-
Cas systems for genome editing in S. islandicus is to en-
force self targeting guided by the crRNA produced from
a plasmid-borne CRISPR array, which will selectively kill
the wild-type cells by targeting the corresponding proto-
spacer for DNA destruction and selectively retain mutant
cells because themutant chromosome contains a non-target
sequence at the corresponding position and is therefore de-
void of the self targeting.
The first step of the experiment is to identify a proto-
spacer on the target gene which will be targeted by the
CRISPR-Cas immune systems once the corresponding cr-
RNA is provided. For Type I and II CRISPR-Cas sys-
tems, a protospacer only serves as a target for DNA de-
struction when it is immediately flanked by a PAM se-
quence at a proper orientation, which can either be pre-
dicted from bioinformatic analysis (8,39), or experimentally
demonstrated (46). Figure 1A illustrates an example of such
a target sequence of Sulfolobus Type I-A systems, includ-
ing a protospacer plus a 5′-flanking CCN-PAM motif on
the template strand of the S. islandicus lacS gene. For Type
III CRISPR-Cas systems, their DNA interference is PAM-
independent but mismatches between the 5′-repeat han-
dle (5–8 nt sequence) and the sequence at its correspond-
ing position on the DNA target trigger the immunity and
the DNA targeting requires transcription at the target site.
Therefore, the protospacer of the lacS gene shown in Fig-
ure 1A also functions as a target for the Cmr- system. It is
important to point out that while DNA targeting by Type I
systems can occur on each of the DNA strands, DNA inter-
ference by Type III systems only targets the template strand
for DNA destruction.
Next, a non-target sequence is to be designed and used
to generate a mutant gene allele with which deletion, inser-
tion or gene mutagenesis can be constructed (Figure 1B).
Here, it is important to design a donor DNA that does not
exhibit any DNA interference activity. This is particularly
relevant to Sulfolobus CRISPR-Cas systems since they ex-
hibit a great tolerance to mismatches between crRNA and
its protospacer (32,34).
Then, a plasmid is to be constructed carrying a mini-
CRISPR array with a spacer designed based on the proto-
spacer of the target gene. Once introduced into Sulfolobus
cells by electroporation, crRNAs expressed from the plas-
mid will guide the endogenous CRISPR system to initiate
DNA interference to the protospacer, and the self-targeting
activity would kill cells carrying the wild-type gene, whereas
cells that have gained a non-target allele of the gene by re-
combination will grow and form colonies (Figure 1C).
Proof-of-concept experiment of CRISPR-based genome-
editing method with the lacS gene
The lacS gene of S. islandicuswas chosen for developing the
method since it encodes a -glycosidase that can be assayed
using X-gal; the wild-type enzyme converts the chemical
into a strong blue substance (designated as LacS+ pheno-
type) whereas its mutants fail to do so (LacS− phenotype).
A spacer was designed according to the protospacer shown
in Figure 1A, and pAC-lacS, an artificial mini-CRISPR
plasmid, was constructed carrying a CRISPR array of a sin-
gle spacer that could produce the crRNAmatching the lacS
protospacer (Figure 1A). Both pAC-lacS1 and the reference
plasmid pSe-Rp were introduced into S. islandicus E233 by
electroporation. The two plasmids gave ca. 104 fold differ-
ence in transformation rate (Table 3), suggesting that the
CRISPRplasmidmediated cell killing, and this is consistent
with the CRISPR-mediated cell killing observed in several
bacteria (18–24).
Next, we tested whether genome editing could be done
by facilitating homologous recombination with donor
DNAs in analogy to genome editing by the well-developed
CRISPR-Cas9 technology (13–15,47). Two different donor
DNA were prepared including a 58-nt oligonucleotide
named LacS-E-SOEF (Table 2) and a double-stranded
DNA segment of 985 bp generated with the splicing
overlap-extension PCR (SOE-PCR) (44) using the primers
listed in Table 2, both of which lacked the target site shown
in Figure 2A. We reasoned that mutant lacS alleles derived
from the recombination between each donor DNA and the
wild-type gene would not be targeted by the DNA interfer-
ence by the CRISPR plasmid.
Each donor DNA was introduced into the ar-
chaeon by transformation together with pAC-lacS
(co-transformation). The number of colonies obtained
from each transformation was comparable to that obtained
with transformation of pAC-lacS alone (Table 3). This
suggested that these colonies could represent escape mu-
tants in which deletions of spacers in CRISPR arrays or
mutations in cas genes inactivated DNA interference, as
observed in previous invader experiments with S. islandicus
and S. solfataricus (32,36,37). Indeed, X-gal screening
revealed that all the colonies were LacS+ and therefore still
carried an active lacS gene. Since S. islandicus is proficient
in homologous recombination as demonstrated by con-
ventional genetic manipulations (27,43,48), the failure of
recovering the designed mutant hinted that the rate of the
CRISPR-mediated genome editing by co-transformation
was much lower than the rate of escaping mutations.
To increase the rate of mutant generation in S. islandicus
cells, a new plasmid vector pGE-lacS1 was constructed, car-
rying both the mini-CRISPR array and its cognate donor
DNA fragment that are exemplified generally in Figure 1C.
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Figure 1. Schematic of the CRISPR-based genome editing in S. islandicus. (A) An example of a crRNA (top strand) and its corresponding DNA target
designed for lacS gene editing with data presented in Figure 2. The target sequence is positioned from +933 to +972 relative to the ATG start codon (+1))
in the lacS gene, including the protospacer (underlined) and a CCT-PAM (protospacer adjacent motif, shown in red). The presence of the 5′-PAM ensures
the Type I-A CRISPR-Cas mediated DNA interference while the mismatch between the 5′-repeat handle and the target sequence (labeled as ‘Mismatch’)
induces DNA interference by the Type III-B Cmr- system. (B) Donor DNAs contain a DNA segment homologous to that flanking the chromosomal
target site but it is altered either by Deletion, or Insertion, or Point mutation, such that it is not to be targeted by the endogenous CRISPR systems.
(C) Two alternative fates for S. islandicus cells transformed with a pGE plasmid. pGE carrying an artificial mini-CRISPR locus with a single spacer and
a donor DNA fragment. The target site is composed of a protospacer and its adjacent sequence, which is to be recognized by a Type I or Type III-B
DNA interference system. If recombination did not occur during transformation, the CRISPR DNA interference selectively targets the wild type gene
for degradation, leading to cell death; if recombination yielded the mutant gene on the chromosome, the mutant cell is devoid of the CRISPR immunity,
forming colonies on plates.
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Figure 2. Generating deletion mutants of lacS gene by CRISPR-Cas systems in S. islandicus. (A) Schematic of the mutant identification by PCR. DNA
target is detailed in Figure 1A, including a protospacer (underlined) and a CCT-PAM (protospacer adjacent motif, shown in red), and it serves as a target
both for the Type I-A and III-B CRISPR-Cas systems. PCR with primers F1/R1 amplifies the donor DNA from pGE-lacS1 whereas PCR with primers
F2/R2 yields PCR products both for the wild-type lacS gene (wt lacS) and for mutant lacS lacking the target site (lacS −). (B) Screening of the enzymatic
activity of lacS in S. islandicus strains using X-gal. X-gal was added into S. islandicus cultures and incubated at 78◦C for 1 h. E233 – S. islandicus pyrEF
mutant as the genetic host for genome editing. E233lacS−– Mutants obtained from pGE-lacS1 transformation. (C) PCR screen of lacS deletion in S.
islandicus strains. PCR with primers F1/R1 specific for pGE vector amplifies the non-target lacS allele (1283 bp) from the plasmid whereas PCR with
primers F2/R2 yields 485-bp and 442-bp DNA fragments that are derived from the wild-type lacS and the deletion mutant allele, respectively. The double
bands indicate an escape mutant (indicated with an arrow). (D) Representatives of the chromatographs of the sequencing results of the wild-type lacS and
its mutant allele lacS−. The protospacer and the CCT-PAMmotif (on the opposite strand) that are highlighted in blue and red, respectively, are present in
the wild-type lacS but absent from lacS−.
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Table 3. Transformation efficiencies of S. islandicus by genome-editing plasmids
Plasmid Strains Transformation efficiency [cfu(g DNA)-1]
pSe-Rp S. islandicus E233 2.6 × 105
pAC-lacS1 S. islandicus E233 37
pAC-lacS1 + LacS-E-SOEF S. islandicus E233 14
pAC-lacS1 + 985-bp PCR DNA S. islandicus E233 22
pGE-lacS1 S. islandicus E233 5.8 × 102
pGE-2-His S. islandicus cas3 3.1 × 103
pGE-2HD S. islandicus E233 cmr- 4.3 × 103
pGE-4W197A E199A Y201A S. islandicus E233 cmr- 4.5 × 102
pGE-1-del S. islandicus E233 cmr- 7.3 × 102
pGE-1W58A F59A S. islandicus E233 cmr- 1.9 × 103
pGE-6G219A G221A S. islandicus E233 cmr- 7.1 × 102
pGE-6L97A Y101A S. islandicus E233 cmr- 6.3 × 102
Transformation was carried out with each plasmid for at least two independent experiments, and the value represents the average of all transformations.
The plasmid was then introduced into S. islandicus E233
by electroporation. Hundreds of colonies were obtained,
which is about 15-fold of the transformation rate with pAC-
lacS (Table 3). Seventeen of themwere picked up and grown
in 5 ml SCVy broth. These cultures were incubated with X-
gal to detect the enzymatic activity of lacS gene. As exem-
plified in Figure 2B, while the culture of the genetic host
showed LacS+, all 5 tested pGE-lacS1 transformants ex-
hibited LacS−. Two sets of primers were then employed to
check the plasmid-borne lacS fragment and themutant lacS
allele in these strains, respectively. As shown in Figure 2C,
PCRwith F1/R1 primers verified that they all carried pGE-
lacS1 whereas PCR with F2/R2 produced a smaller PCR
product in all 17 strains, representing the designed lacSmu-
tant of the predicted size of 442 bp. Furthermore, a slightly
larger PCR product was present in Strain 11 (indicated by
an arrow) but absent from all other tested strains, this PCR
product is very similar in size to the predicted PCR product
of thewild-type gene (485 bp) (Figure 2C).Next, PCRprod-
ucts of the entire lacS gene were generated using LacS-Seq-
F/LacS-Seq-R primers (Table 2) and sequenced by DNA
sequencing. Therefore, only Strain 11 carried the wild-type
lacS gene while all remaining16 strains harbored the de-
signed lacS mutant. Together these results indicated that
pGE-lacS1 mediated accurate genome editing in S. islandi-
cus at a high efficiency.
Although there are a few reports on CRISPR-mediated
genome editing for bacteria in the current literature, only
Type II CRISPR-Cas9 systems have been employed for the
purpose. In their pioneer research of conducting bacterial
genome editing, Jiang et al. (2013) employed two differ-
ent plasmids for genome editing in E. coli, one carried the
cas9 and the tracrRNA gene of the Streptococcus pyogenes,
while the other plasmid carry an artificial CRISPR array
(21). The CRISPR-Cas systemwas introduced into the bac-
terium in the first transformation while the CRISPR ar-
ray and donor DNA were co-electroporated into the cas9-
carrying E. coli at the second transformation. However, the
co-transformation that worked in E. coli genome editing
failed in S. islandicus, which probably reflects that E. coli
can be transformed by electroporation at a much higher
rate (>103-fold) than Sulfolobus. This is also true for Lac-
tobacillus reuteri in which a recT gene has to be included
in order to facilitate the recombination process based on a
single stranded donor DNA (49). We constructed genome-
editing plasmids carrying both a CRISPR array and a
donor DNA fragment and found that they greatly elevates
genome-editing efficiencies in S. islandicus. Furthermore,
successful genome editing was recently reported for using
a single plasmid carrying the cas9 gene, the sgRNAmodule
and homology regions (50–52). Therefore, the strategy of
using a single plasmid for genome editing based on endoge-
nous CRISPR-Cas systems should be generally applicable
to many other bacteria and archaea as demonstrated in Sul-
folobus.
When the CRISPR-based genome editing method devel-
oped here is compared with the routine genetic manipula-
tion recently developed for S. islandicus (26,27), the former
method exhibits several advantages over the latter. First, it
takes only up to 3 weeks to generate gene mutants by using
the CRISPR-Cas genome editing whereas employing the
plasmid integration and targeting deletion previously de-
veloped in our laboratory requires >6 weeks to accomplish
the same task. This is because growing colonies of pGE-
lacS1 transformants in the selective broth yields pure cul-
tures of the desired mutant whereas for a routine Sulfolobus
genetic manipulation, strains need to be purified each time
after colonization on plate. Second, preparation of plas-
mids for CRISPR-Cas genome editing requires a two-step
cloning, comparing with three relatively large fragments
to be cloned in the routine genetic manipulation. Finally,
whereas pGE plasmids are replicative and will be main-
tained during growth, knockout plasmids are linearized sui-
cide plasmids to be lost during incubation, and this ac-
counts for a much higher transformation rate (>100-fold)
with pGE plasmids comparing with that of gene knockout
plasmids. Taken together, CRISPR-Cas genome editing de-
veloped here has greatly simplified the procedure of genetic
manipulation in S. islandicus.
In situ gene tagging of cmr-2 gene by repurposing a Type
III-B system
Next, we employed this approach for generating S. islandi-
cus strains to produce an in situ tagged protein. We chose
to work on Cmr-2, a Cas10 homolog of the S. islandicus
Cmr- system. Cas10 is the type-specific Cas protein for
Type III systems (3), which is implicated in DNA interfer-
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Figure 3. In situ gene tagging of cmr-2α. (A) Schematic of in situ gene tagging strategy. The protospacer is underlined in which the TGA stop codon of
cmr-2 is indicated with an asterisk. Mismatches between the 3-flanking DNA stretch of the protospacer and the 5′ repeat handle of the crRNA facilitate
DNA interference to the wild-type cells by Type III-B Cmr- as experimentally demonstrated previously (36). Insertion of 6x His codons in the middle
of the protospacer yields a non-target cmr-2 gene. Therefore, cells that carry His-tagged cmr-2 gene are devoid of the DNA interference and selectively
retained. (B) PCR screening of cmr-2-His recombinants generated with S. islandicuscas3. Primers F3 is specific for genome DNAwhile R3 contains the
18 nt encoding the 6xHis tag. All 12 tested strains carry the in situ tagged gene. (C) Representative chromatographs of the sequencing results of the wild-type
cmr-2 and cmr-2-His recombinants. Precise insertion of His-tag coding sequence (highlighted in blue) in front of the stop codon was observed in all
analyzed strains. (D) Co-purification of the Cmr- complex by nickel affinity chromatography purification of His-tagged Cmr-2. Proteins were stained
with Silver staining. (E) Western analysis of His-tagged Cmr-2 using antibody specifically recognizes the His-tag peptide. A peptide of the predicted size
is hybridized. The DNA replication protein PCNA3 was used as a reference.
ence (53–56). Here, we tested whether Type III Cmr-DNA
interference could be repurposed for the in situ gene tag-
ging for the cmr-2 gene in this archaeon. A spacer was de-
signed containing the last 19-bp coding sequence of cmr-2,
6-bp intergenic sequence and the first 7-bp of cmr-3, which
yields a 6xHis-tagged version of Cmr-2 at the C-terminus.
The spacer DNA fragment was generated by annealing of
the two oligonucleotides listed in Table 2 and cloned to
pSe-Rp, giving pAC-2-His. Then, a donor DNA (1223
bp) generated by SOE-PCR using oligonucleotides listed in
Table 2 was cloned to pAC-2-His, yielding the genome-
editing plasmid pGE-2-His. To ensure that genome edit-
ing is solely based on the Type III-B system, transformation
with pGE-2-His was conducted with S. islandicus cas3,
which is devoid of the Type I-A DNA interference. Thou-
sands of colonies were obtained (Table 3), indicating that
the Cmr- system is very efficient inmediating genome edit-
ing.
To reveal the genotype of transformants, their genomic
DNAs were used as template for PCR analysis using F3
and R3 (Table 2) to amplify a DNA fragment encompass-
ing the edited genomic region. Twelve colonies were tested
and they all yielded a PCR product of the predicted size,
which is absent from the original host (Figure 3B), suggest-
ing that all 12 tested strains carried the His-tagged version
of cmr-2 gene. The authenticity of the His-tagged gene
was confirmed for all 12 strains by amplifying a PCR frag-
ment of cmr-2 using primers of 2-Seq-F and 2-Seq-R
(Table 2) for DNA sequencing (Figure 3C). Furthermore,
the tagged Cmr-2 protein was purified via nickel affin-
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Figure 4. Mutagenesis of cmr-2 HD domain. (A) A sequence alignment of the N-termini of S. islandicus Cmr-2 (SiRe-0894), Cmr-2 (SiRe-0598) and
its Pyrococcus furiosus homolog PF1129. Four conserved amino acids were chosen for constructing substitution mutations (indicated with red asterisks).
(B) Schematic of the mutagenic strategy. The I-A target site is underlined and bases highlighted in red are to be mutated whereas bases highlighted in blue
represent mutated bases present in DNA donor. The donor DNA containing mutations on the PAM and/or the seed sequence that inactivate the Type I-A
DNA interference activity is provided for recombination. (C) Chromatographs of the sequencing results for the three types of cmr-2mutant. Sequencing
of seven transformants yielded three different types of mutant, carrying either HD mutation, or HD+K mutation or all four designed mutations.
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ity purification, which led to the co-purification of a pro-
tein complex containing all Cmr- proteins of the predicted
sizes (Figure 3D). In fact, this complex resembles an ac-
tive Cmr- complex that was purified by Cmr-6 tagged pu-
rification (unpublished data). A few additional proteins of
small sizes were co-purified in the Cmr-2 purification (Fig-
ure 3D), and these proteins were also present in the Cmr-6
co-purification. But these small proteins are not part of the
Cmr- complex since they have subsequently been removed
by gel filtration (data not shown). Furthermore, western
blot analysis using a commercial antiserum that specifically
recognizes the His tag peptide revealed that a protein band
of ca. 100 kDa, which is consistent with the predicted size
of S. islandicus Cmr-2 (102.1 kDa) (Figure 3E). Together,
these results suggest that protein co-purification using in
situ tagged gene represents a useful method in studying
protein-protein interaction in vivo.
Generation of substitution mutations by repurposing Type I-
A DNA interference
Then, we attempted to construct genes containing point
mutations to replace site-directed mutagenesis in vitro.
Again, the S. islandicus cmr-2 gene was used to test in vivo
mutagenesis of multiple sites in order to identify the active
site of DNA cleavage in the Cmr complex. All conserved
Cas10motifs in Cmr-2were subjected to mutagenesis, and
here we started with the HD domain in the N-terminus. In-
spection of the coding sequence revealed a CCA-PAMmo-
tif overlapping with the HD (histidine and asparatic acid)
codons. Thus, the downstream 40 nt was regarded as a pro-
tospacer (Figure 4A) with which two oligonucleotides were
designed to generate the corresponding spacer DNA frag-
ment that was cloned to pSeRp vector, giving pAC-Sp-cmr-
2HD1. Then, a DNA fragment carrying four amino acid
substitutions in the HD domain including H14N, D15N,
K19Aand I23Awas obtained by SOE-PCRand cloned into
pAC-Sp-cmr-2HD1, yielding pGE-2HD (Figure 4B). To
avoid any possible influence of Cmr- on the function of
cmr-2, a S. islandicus cmr- constructed previously (38)
was employed. The genome-editing plasmid was introduced
into the host by electroporation, yielding a transformation
rate comparable to the above experiments. Analysis of Cmr-
2 gene in seven transformants revealed that three different
types of cmr-2mutants, amongwhich four of them showed
all four mutations, one carried the HDmutation along with
K19A whereas the last two only carried the HD mutation
(Figure 4C). Notably, recombination occurred for the two
sites separated only by 11 bp, suggesting that the persistence
of several copies of donor DNA on the plasmid vector (due
to the nature of multiple copies of the plasmid (43)) renders
it possible to recover a low frequency of homologous re-
combination. These results also indicated that multiple sub-
stitutions are obtainable from the same CRISPR-mediated
genetic manipulation.
We did the same for a few other cmr- genes including
cmr-1, -4 and -6 and the designed mutants were ob-
tained readily in all experiments with a donor DNA car-
rying a mutation in its PAMmotif (Table 3). However, for a
few pGE plasmids in which the PAM is not changed in the
donor DNA, transformation rate was seriously impaired,
and mutants were only obtained from transformation with
some pGE plasmids (unpublished data), suggesting that
these donor DNAs was still targeted by the CRISPR im-
munity albeit at a lesser extent. These results are consistent
with the previous finding that DNA targeting by Sulfolobus
Type I-A tolerate multiple mismatches (32,34). Therefore,
it is very important to mutate the PAM motif on any I-A
DNA target when generating non-target DNA for gene mu-
tagenesis.
In summary, we show that S. islandicus endogenous
CRISPR-Cas systems can be repurposed for genetic manip-
ulation including deletion, insertion and site-specific muta-
genesis (Figure 1B) and the developed procedures are more
straightforward than the classic geneticmanipulations. Fur-
thermore, we have successfully conducted genome editing
in another Sulfolobus strain, i.e. S. islandicus HVE10/4 by
repurposing its endogenous Type I-A CRISPR-Cas system
(unpublished data), which has widely been used as a host for
virus study (41) but is constantly refrained from any rou-
tine genetic manipulations since electroporation can only
yield a low level of transformation to this archaeon. We
envision that the CRISPR-Cas genome editing strategy re-
ported here is generally applicable to all archaea and bac-
teria that encode an active CRISPR-Cas system, represent-
ing a simpler CRISPR-based genome editing tool than the
existing CRISPR-Cas9 technology for genome editing. In
particular, since Type II CRISPR-Cas systems are limited
to a few taxa of mesophilic bacteria, their activity needs to
be tested vigorously and even improved by mutagenesis be-
fore applied in other physiological groups of organisms in-
cluding thermophilic bacteria and archaea. By contrast, any
active endogenous CRISPR-Cas system can readily be ap-
plied in genome editing although application of a Type I
or Type II CRISPR-Cas system will require to obtain the
knowledge of its PAM sequence by bioinformatic analysis
as demonstrated previously (8,39).
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